(Q33910129)

30 July 2017

Strategies for managing depression refractory to selective serotonin reuptake inhibitor treatment: a survey of clinicians (English)

1 reference

30 July 2017

D Mischoulon

1

1 reference

30 July 2017

A A Nierenberg

2

1 reference

30 July 2017

L Kizilbash

3

1 reference

30 July 2017

J F Rosenbaum

4

1 reference

30 July 2017

M Fava

5

1 reference

30 July 2017

language of work or name

English

0 references

publication date

1 June 2000

1 reference

Canadian Journal of Psychiatry

30 July 2017

1 reference

30 July 2017

45

1 reference

30 July 2017

5

1 reference

30 July 2017

476-481

1 reference

Definition and epidemiology of treatment-resistant depression

30 July 2017

1 reference

https://api.crossref.org/works/10.1177%2F070674370004500509

Lithium and tricyclic augmentation of fluoxetine treatment for resistant major depression: a double-blind, controlled study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370004500509

A review of the use of augmentation therapy for the treatment of resistant depression: implications for the clinician

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370004500509

Serotonergic autoreceptor blockade in the reduction of antidepressant latency: personality variables and response to paroxetine and pindolol.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370004500509

Buspirone augmentation of selective serotonin reuptake inhibitors (SSRIs) in social phobia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370004500509

Strategies for augmentation of SSRI treatment: a survey of an academic psychopharmacology practice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370004500509

10.1177/070674370004500509

21 January 2018

Identifiers

DOI

1 reference

30 July 2017

1 reference